Sacerdotus: use of cannabis and colon cancer: a new study

Use of cannabis and colon cancer: a new study

Recent research has sparked warmly discussion about the risks of marijuana use, especially those who fight serious diseases like colon cancer. A study published by Screamice researchers at the University of San Diego University had a striking correlation: patients with a high-use history of cannabis is more than 20 times more likely to be killed within five years of diagnosis. This discovery, while worrying, poses important questions about the effect of cannabis in the results of cancer and emphasizes more research. Let’s do it in the details of the study, explore his implications and consider the wider context of cannabis and cancer.

Study: What researchers found

The UC San Diego team studied electronic records of patients with Cancer of California and University of 2024. Before the diagnosis of cancer, before the diagnosis of cannabis, specifically, the use of cannabis (CUD) indicated a clinical diagnosis. After controlling the factors of age, sex, tumors and cancer biomarkers, the results were tough: patients with Cud kill 56% to kill, 5% compared to 5%. This folds 24 times to increase the risk of mortality for large cannabis users.

Raphael Cuomo, the headliter of the UC San Diego Department of Anesthetiology, has emphasized that the great use of cannabis can affect the immune system, mental health and treatment behaviors. For example, the use of high cannabis is often associated with depression and anxiety, which can interfere with a patient’s ability to fully link to cancer treatment. The study suggests these factors, driving the risk of mortality risk than the direct effect of cancer cells.

Context: Kannabis and cancer research

This study adds a new layer in a complex relationship between cannabis and cancer. On the one hand, some studies have proposed potential benefits. The 2019 Penn State College exam found that some synthetic cannabinoid compounds inhibited the growth of colon cancer cells in laboratory tests. The other 2020 mice examination showed Tetrahydrocanabinol (THC), cannabisan compound linked to psychoactive compounds, inflammation and prevent colon cancer. These discoveries have had the hope that cannabis has been in the treatment or prevention of cancer.

However, the UC St. Diego study stands out a different side of the story. While laboratory studies promise, the real use of the real world of cannabis is much more difficult. Researchers stated that due to high concentrations mentioned in a previous post, it is thousands of times larger than the ground, as they produce maritime life. This comparison, although it has nothing to do with cannabis, indicates context in interpreting chemical or biological consequences. Also, cannabis can be the presence of other conditions such as the effects of patients with colon cancer patients, individual health factors and mental health challenges.

Critical appearance: What is missing?

While the UC is a compelling study of San Diego, it is not limited. First of all, it is based on retrospective data, which is not proved that the use of cannabis directly caused by a higher mortality rate, it only shows an association. Patients with Cud may have other risk factors, such as general health or socio-economic barriers, were not fully accounted. Second, examination does not explore the mechanisms behind the great mortality. Do Cannabis weakens the ability to fight the immune system? Does it interfere with chemotherapy? Or is the problem greater behavior, heavy users have less likely to retain treatment plans? These questions remain unanswered.

In addition, exams is a view of the use of heavy cannabis, specifically, Cud means that they are not moderate or occasionally applied. The systematic review of 2019 has not found a clear association between marijuana use and cancer development, although there is a higher risk for other cancers, between heavy users. This suggests that risks can be dependent on doses, the UC St. Diego examination does not fully address.

The narrative about Kannabis is worth questioning. The study has shared a lot on platforms like X, marking messages as a warning against marijuana use. However, this risk exceeds the problem. Cannabis is not a monolith, its effects vary depending on the voltage, the method of use and individual factors. Vilizing Cannabis suggests that some reactions excludes its potential benefits to manage symptoms, 2021 Colorenal cancer surviving in the study of the Fred Hutchinson Cancer Center. 40% of cancer patients use cannabis to relieve symptoms such as nausea and pain, often with positive results.

Involvements and path forward

UC San Diego research does not cause cannabis causing colon cancer or bends directly. Instead, it is about the correlation that requires more research. Cannabis used 4.5 million young people used in 2023, depending on drugs and health national surveys, participations are high. This is mainly due to the medically weak populations of patients with cancer, to get relief according to cannabis, but unintentional facial risks if they become heavy use.

For patients, this study emphasizes the importance of open conversations with health suppliers. Considering cannabis, if you had colon cancer, discuss your use patterns with your oncology team. For researchers, the analysis is a call for action. We need to follow Kannabis’s use before and after a diagnosis of cancer, as well as research on biological pathways like the effects of the immune system.

Conclusion: Balanced view

The UC is a tough reminder reminder of the study of San Diego, although cannabis, growing acceptance, is no danger, especially for those with serious diseases like colon cancer. Heavy use may be related to worse results, but why is not clear. At the same time, the exclusion of cannons has excluded its potential benefits to alleviate symptoms as well as for cancer prevention, as other research suggests. It is true that it is likely to be in the middle: cannabis can be support and obstacle, how it is used and for whom it is used. When we are waiting for more research, the best view is prudence, curiosity and honest conversation, both in the public and public square.

---

Sources

• Published by Medical School of San Diego University of California, April 28, 2025, Epidemiology Annals.

• Penn State College of Medicine, 2019, published Kannabis and cannabinoid research.

• New medicine today, on October 3, 2020, study Thc and Columbus cancer at mice.

• National Drug and Health Survey, 2023 Between 2023 young data on cannabis.

• Fred Hutchinson Cancer Center, 2021, use of cannabis among those surviving of Colorectal cancer, published Cancer causes and control.

• Systematic review of the use of marijuana and cancer risks published in 2019 Cancer epidemiology, biomarkers and prevention.